103 related articles for article (PubMed ID: 30942451)
1. Combination of SB431542, CHIR99021 and PD0325901 has a synergic effect on abrogating valproic acid‑induced epithelial‑mesenchymal transition and stemness in HeLa, 5637 and SCC‑15 cells.
Zhang Y; Zhang Y; Li M; Meng F; Yu Z; Chen Y; Cui G
Oncol Rep; 2019 Jun; 41(6):3545-3554. PubMed ID: 30942451
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma.
Chua KN; Kong LR; Sim WJ; Ng HC; Ong WR; Thiery JP; Huynh H; Goh BC
Oncotarget; 2015 Oct; 6(30):29991-30005. PubMed ID: 26358373
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways.
Liao S; Gan L; Qin W; Liu C; Mei Z
Oncol Rep; 2018 Oct; 40(4):2005-2013. PubMed ID: 30066938
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
5. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
6. The small molecule inhibitors PD0325091 and CHIR99021 reduce expression of pluripotency-related genes in putative porcine induced pluripotent stem cells.
Petkov S; Hyttel P; Niemann H
Cell Reprogram; 2014 Aug; 16(4):235-40. PubMed ID: 24960205
[TBL] [Abstract][Full Text] [Related]
7. The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition.
Ishida R; Koyanagi-Aoi M; Oshima N; Kakeji Y; Aoi T
Mol Cancer Res; 2017 Oct; 15(10):1455-1466. PubMed ID: 28710230
[TBL] [Abstract][Full Text] [Related]
8. Application Of Small Molecules Favoring Naïve Pluripotency during Human Embryonic Stem Cell Derivation.
Van der Jeught M; Taelman J; Duggal G; Ghimire S; Lierman S; Chuva de Sousa Lopes SM; Deforce D; Deroo T; De Sutter P; Heindryckx B
Cell Reprogram; 2015 Jun; 17(3):170-80. PubMed ID: 26053517
[TBL] [Abstract][Full Text] [Related]
9. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting glycogen synthase kinase-3 and transforming growth factor-β signaling to promote epithelial transition of human adipose mesenchymal stem cells.
Setiawan M; Tan XW; Goh TW; Hin-Fai Yam G; Mehta JS
Biochem Biophys Res Commun; 2017 Sep; 490(4):1381-1388. PubMed ID: 28698144
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
[TBL] [Abstract][Full Text] [Related]
12. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
13. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition.
Katsuno Y; Meyer DS; Zhang Z; Shokat KM; Akhurst RJ; Miyazono K; Derynck R
Sci Signal; 2019 Feb; 12(570):. PubMed ID: 30808819
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells.
Jahani M; Khanahmad H; Nikpour P
J Gastrointest Cancer; 2021 Jun; 52(2):676-681. PubMed ID: 32621111
[TBL] [Abstract][Full Text] [Related]
15. Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer.
Ozman Z; Ozbek Iptec B; Sahin E; Guney Eskiler G; Deveci Ozkan A; Kaleli S
Mol Biol Rep; 2021 Feb; 48(2):1335-1343. PubMed ID: 33515347
[TBL] [Abstract][Full Text] [Related]
16. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
17. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q
J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
